Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72721 record(s)

Req # A-2020-001736

All seizure records from British Colombia in 2019 and 2020 in the Office of Controlled Substances (OCS) - Controlled Drugs and Substances Database (CDSD) and Drug Analysis Service (DAS) - Laboratory Information Management System (LIMS).

Organization: Health Canada

916 page(s)
August 2024

Req # A-2021-001884

Referring to following web site for regulating vaccines: <https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/fact-sheets/regulation-vaccines-human-canada.html>.…

Organization: Health Canada

947 page(s)
August 2024

Req # A-2021-001964

All documents submitted by BioNTech Manufacturing Company GmbH or Pfizer as part of the regulatory review that resulted in the Regulatory Decision Summary (Interim Order) dated December 9, 2020 for the Comirnaty Vaccine. The full regulatory review…

Organization: Health Canada

518 page(s)
August 2024

Req # A-2022-000244

Any communication around (proposed) amendments to the International Health Regulations (https://www.who.int/health-topics/international-health-regulations#tab=tab_1), since June 1, 2021.

Organization: Health Canada

90 page(s)
August 2024

Req # A-2022-000443

All memos, briefing notes, emails and reports between the Health Ministers office and the Canadian Cancer Society from January 1, 2020 to July 1, 2022 about the COVID-19 pandemic and cancer.

Organization: Health Canada

97 page(s)
August 2024

Req # A-2022-001297

All documents relating to the applications for the following authorization reference numbers. Authorization Reference Number 327866, issued on October 20, 2021; Authorization Reference Number 318801, issued on May 5, 2021; Amendment Reference Number…

Organization: Health Canada

2442 page(s)
August 2024

Req # A-2022-001596

The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the medical devices establishment licence inspection of the Ferring facility on Yorkland Road,…

Organization: Health Canada

425 page(s)
August 2024

Req # A-2022-001597

The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the medical device establishment licence inspection of the Ferring facility on Yorkland Road,…

Organization: Health Canada

590 page(s)
August 2024

Req # A-2023-000307

All correspondence between Health Canada employees Pierre Sabourin or David Boudreau and BTNX, Inc., between April 1, 2020 and November 30, 2022.

Organization: Health Canada

176 page(s)
August 2024

Req # A-2023-000733

The initial cover letter and any other document indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-08-17 for the medicinal…

Organization: Health Canada

53 page(s)
August 2024
Date modified: